| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.490 | 30.101 | 32.459 | 37.670 | 46.299 | 57.658 | 78.394 | 66.674 | 83.091 | 94.577 |
| Total Income - EUR | 28.490 | 30.102 | 32.459 | 37.671 | 46.300 | 59.727 | 78.396 | 66.676 | 83.093 | 97.102 |
| Total Expenses - EUR | 15.816 | 13.776 | 16.413 | 15.118 | 20.790 | 18.894 | 17.290 | 20.128 | 19.735 | 30.959 |
| Gross Profit/Loss - EUR | 12.674 | 16.325 | 16.046 | 22.553 | 25.510 | 40.833 | 61.106 | 46.549 | 63.358 | 66.143 |
| Net Profit/Loss - EUR | 11.819 | 15.723 | 15.721 | 22.176 | 25.047 | 40.441 | 60.322 | 45.882 | 62.527 | 63.298 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
Check the financial reports for the company - Gabilucmed 54 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 2.149 | 3.915 | 2.642 | 1.673 | 5.708 | 6.808 |
| Current Assets | 15.365 | 19.150 | 19.537 | 26.921 | 27.862 | 43.773 | 63.073 | 77.987 | 62.609 | 62.877 |
| Inventories | 3 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.663 | 1.280 | 2.701 | 3.213 | 3.905 | 30.926 | 8.391 | 33.477 | 50.029 | 25.013 |
| Cash | 13.698 | 17.848 | 16.837 | 23.708 | 23.958 | 12.847 | 54.682 | 44.510 | 12.580 | 37.864 |
| Shareholders Funds | 14.685 | 18.569 | 18.652 | 25.443 | 28.924 | 44.422 | 64.340 | 49.913 | 66.545 | 67.293 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 679 | 581 | 885 | 1.478 | 1.087 | 3.266 | 1.376 | 29.748 | 1.772 | 2.392 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Gabilucmed 54 Srl